biotechnology analyst News

FDA is Green-Lighting Drugs at Breakneck Speed and Raising Alarm

The U.S. is approving new drugs so fast that companies are now preparing for a green light months in advance of the scheduled decision date, a pace that’s helping patients with rare or untreatable diseases but raising alarm among consumer …